Diabetes in the elderly: is age a limiting control target?
- International Journal of Family & Community Medicine
-
ANCI Alvarez Cynthia Antonella, Solavallone Vanina, Dromi Luz Carolina, Lavandaio Hugo, Marcucci Guillermo
Abstract
Goals: To compare demographic, anthropometric and clinical characteristics in diabetic > and <65 years and to determine the impact of age on the control target.
Methods: Observational, prospective and comparative study. Diabetic patients attended as outpatients were analyzed in Lagomaggiore Hospital, recorded in our database until August 2017. Patients with diabetes >65 years were compared with the rest of the diabetic population. Variables studied were: demographic, anthropometric, type of diabetes mellitus (DM), micro and macrovascular complications (MAP), compliance glycemic control targets (GCT), lipid (LipCT), blood pressure (BPCT), microalbuminuria and/or proteinuria (MPCT), current smoking (TABA). Analysis: MedCalc.
Results: 364 diabetic patients were included, 60 (16.5%) had >65 years. Comparative analysis: Male 25 (41.7%) vs 85 (28.0%) p 0.04. >10 years of evolution: 41 (68.3%) vs 108 (35.6%) p<0.001. DM type2: 58 (96.7%) vs 255 (83.9%) p 0.01. Arterial hypertension (AH): 51 (85%) vs 193 (63.5%) p 0001. Acute myocardial infarction 15 (25%) vs 17 (5.6%) p<0.001. Heart failure: 16 (26.7%) vs 34 (11.2%) p 0.001. MAP: 20 (33.2%) vs 39 (12.8%) p<0.001. Retinopathy: 35 (64.8%) vs. 144 (52%) p 0.08. Neuropathy: 15 (25%) vs 45 (14.8%) p 0.05. Chronic kidney disease state 3 and 4: 16 (27.6%) vs 35 (11.8%) p 002. BPCT: 49 (81.7%) vs 252 (82.9%) p 0.8. GCT: 33 (55.9%) vs 137 (46.6%) p 0.2. LipCT: 29 (50.9%) vs. 144 (49%) p 0.8. MPCT: 40 (71.4%) vs 176 (63.3%) 0.2 p. TABA: 5 (8.3%) vs 66 (21.7%) 0.01 p.
Conclusions: Our diabetics patients >65 years had more comorbidities, cardiovascular risk factors and macrovascular complications. Despite this, there was no difference in achieving control target or medication use.
Keywords
diabetes mellitus, elderly, comorbid, medication, glycemic control targets, blood pressure, diabetic patients, heart failure